- Home
- DYAI vs ICMB Comparison
DYAI vs ICMB Comparison
Compare DYAI & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DYAI | ICMB |
|---|---|---|
| Founded | 1979 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0M | 17.2M |
| IPO Year | 2026 | 2013 |
Fundamental Metrics
Financial Performance| Metric | DYAI | ICMB |
|---|---|---|
| Price | $0.44 | $0.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 179.7K | 33.3K |
| Earning Date | 11-11-2026 | 11-11-2026 |
| Dividend Yield | N/A | ★ 20.78% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,090,345.00 | N/A |
| Revenue This Year | $113.16 | $5.32 |
| Revenue Next Year | $94.92 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.34 | $0.65 |
| 52 Week High | $1.60 | $3.12 |
Technical Indicators
Market Signals| Indicator | DYAI | ICMB |
|---|---|---|
| Relative Strength Index (RSI) | 39.53 | 20.86 |
| Support Level | $0.34 | N/A |
| Resistance Level | $0.50 | $0.88 |
| Average True Range (ATR) | 0.04 | 0.05 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 56.77 | 8.08 |
Price Performance
Historical ComparisonAbout DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). The investment objective of the company is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.